Sutent® Gains FDA Approval To Treat Pancreatic Neuroendocrine Tumors
Links shared publicly online about this topic.
- 278total visits
Sutent® Gains FDA Approval To Treat Pancreatic Neuroendocrine Tumors
View full resource at medicalnewstoday.com
Tags: Pancreatic Disease, Diet and Nutrition, Drug, FDA, Pfizer
Most Recently Shared on May 21, 2011 at 7:05 am By:
Sutent® Gains FDA Approval To Treat Pancreatic Neuroendocrine Tumors http://mnt.to/3Wb8 #pancreaticcancer
Also Shared By:
Comments of tuberculosis in the use of Sutent - eHealthMe.com
ehealthme.com — “I was taking sutent for cancer that starte in my kidney. I had a biopsy taken from my lung and was told I had tuberculosis. I had to stop taking sutent because of the antibiotics I need to handle the tuberculosis. I have since learned it was a cross contamination issue and I do not have tb. Can I take sutent again? It was actually working better and faster than the chemo.” View full resource at ehealthme.com
Most Recently Shared on March 18, 2012 at 2:36 pm By:
I was taking sutent for cancer that starte in my kidney. I had a biopsy taken from my lung and was told I had http://t.co/Xi3FwMaz
Sunitinib plus docetaxel fails as first-line therapy for advanced breast cancer - The Doctor's Channel
thedoctorschannel.com — “NEW YORK (Reuters Health) – Adding the multitargeted tyrosine kinase inhibitor sunitinib (Sutent; Pfizer) to docetaxel did not improve clinical outcomes when used in the first-line setting in a phase III open-label study of women with HER2/neu-negative advanced breast cancer....” View full resource at thedoctorschannel.com
Most Recently Shared on February 24, 2012 at 8:54 pm By:
Dr Michael Banks - The Doctor's Channel Health Site
What are your thoughts on the results of this study? - From Reuters Health/TDC http://t.co/MK8EkB4F #cancer #health #women
University of Michigan study shows Avastin, Sutent increase breast cancer stem cells: http://t.co/oBTNnbiF
snsanalytics.com — “University of Michigan study shows Avastin, Sutent increase breast cancer stem cells: http://t.co/oBTNnbiF” View full resource at snsanalytics.com
Most Recently Shared on January 27, 2012 at 2:23 pm By:
Cancer News Network Health News
University of Michigan study shows Avastin, Sutent increase breast cancer stem cells: http://t.co/oBTNnbiF
Sutent, Round 1: Dental Harpies, Wood Glue and Forrest Gump | ACKC
ackc.org — “Kidney cancer survivor Chris Battle discusses side effects after his first cycle on Sutent.” View full resource at ackc.org
Most Recently Shared on October 19, 2011 at 9:21 pm By:
ACKC Health Organization and Nephrology
ACKC blog: Sutent, Round 1: Dental Harpies, Wood Glue, and Forrest Gump http://t.co/JzC0Dp8Y
Plexxikon's Hirth offers a "small" solution to Big Pharma's R&D woes - FierceBiotech
fiercebiotech.com — “Over the years Peter Hirth has gradually perfected his smaller-is-better approach to developing new drugs. As president of Sugen he played a big role in creating Sutent before selling the company. Read more...” View full resource at fiercebiotech.com
Most Recently Shared on September 7, 2011 at 2:07 pm By:
Plexxikon's Hirth offers a "small" solution to Big Pharma's R&D woes http://t.co/L21rLty
Serial Lifesaver - Forbes
forbes.com — “From the September 26 issue of Forbes: ?Peter Hirth is showing the pharmaceutical industry a nimbler way to come up with breakthrough medicines. When K. Peter Hirth had his first big success as a pharmaceutical inventor, he celebrated by quitting his job. [...]” View full resource at forbes.com
Most Recently Shared on September 6, 2011 at 8:08 pm By:
Luke Timmerman Health Communicator
RT @matthewherper: Plexxikon's Peter Hirth on inventing new drugs: "It doesn't take an army." http://ow.ly/6n23n
FDA Approves Sutent For Rare Type Of Pancreatic Cancer
medicalnewstoday.com — “The U.S. Food and Drug Administration approved Sutent (sunitinib) to treat patients with progressive neuroendocrine cancerous tumors located in the pancreas that cannot be removed by surgery or th” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 7:06 am By:
MNT Pancreatic Can Health News
FDA Approves Sutent For Rare Type Of Pancreatic Cancer http://mnt.to/3WmW #pancreaticcancer
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 24, 2011 at 12:49 am By:
Jennifer Ann Grisso Active Health Library and Nurse
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administratio... http://bit.ly/jHoEuw
Sutent Approved for Rare Pancreatic Cancer - Drugs.com MedNews
drugs.com — “U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or” View full resource at drugs.com
Most Recently Shared on May 23, 2011 at 10:54 pm By:
Sutent Approved for Rare Pancreatic Cancer - http://bit.ly/jtQdz9
FDA Approves Sutent for Pancreatic Cancer
onclive.com — “The FDA has approved Sutent (sunitinib) for the treatment of patients with unresectable, locally advanced, or metastatic pancreatic neuroendocrine tumors (pNET)” View full resource at onclive.com
Most Recently Shared on May 23, 2011 at 9:54 pm By:
The FDA has approved Sutent (sunitinib) for unresectable pancreatic neuroendocrine tumors (pNET) http://goo.gl/MnX17
Sutent Approved for Rare Pancreatic Cancer
health.yahoo.net — “MONDAY, May 23 (HealthDay News) -- U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or has metastasized to other parts of the body.” View full resource at health.yahoo.net
Most Recently Shared on May 23, 2011 at 5:19 pm By:
allergydropz Doctor, Surgeon, ENT Doctor, and Physician
Yahoo health: Sutent Approved for Rare Pancreatic Cancer http://bit.ly/lrohqJ Full http://bit.ly/lP8e3J
Sutent Approved for Rare Pancreatic Cancer - Drugs.com MedNews
drugs.com — “U.S. Food and Drug Administration approval of Sutent (sunitinib) has been expanded to include people with neuroendocrine pancreatic cancer that is inoperable or” View full resource at drugs.com
Most Recently Shared on May 23, 2011 at 5:08 pm By:
Drugs and Devices OW OW Health
Sutent Approved for Rare Pancreatic Cancer: MONDAY, May 23 -- U.S. Food and Drug Administration approval o... http://bit.ly/jEXC4f #drug
Sutent Gains Indication for Advanced Pancreatic Tumors - ONA
oncologynurseadvisor.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 23, 2011 at 2:50 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Sutent Gains Indication for Advanced Pancreatic Tumors http://goo.gl/fb/AhvBJ
Sutent Gains Indication for Advanced Pancreatic Tumors - MPR
empr.com — “The FDA has approved Sutent (sunitinib malate; Pfizer) for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors in patients with unresectable locally advanced or metastatic disease.” View full resource at empr.com
Most Recently Shared on May 23, 2011 at 2:35 pm By:
MPR News: Sutent Gains Indication for Advanced Pancreatic Tumors: The FDA has approved Sutent (sunitinib malate;... http://bit.ly/klWR8Y
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
medicalnewstoday.com — “Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SUTENT® (sunitinib malate) as the first anti-VEGF therapy to treat progressive, well-differentiated pa” View full resource at medicalnewstoday.com
Most Recently Shared on May 23, 2011 at 9:05 am By:
MNT Gastrointestinal Health News
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors http://mnt.to/3Wcr #gastrointestinal
Advertisement
MNT Drug Approvals
@mnt_drugapprov
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors http://mnt.to/3Wcr #regulatory
1 year ago...